Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruijie Wang

Showing results (221-230 of 225) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 225 results.
Nature Communications|July 23, 2022
Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatmentMoataz Reda, Worapol Ngamcherdtrakul, Molly A Nelson, et al.
Science (New York, N.Y.)|February 13, 2025
Ultrastable supported oxygen evolution electrocatalyst formed by ripening-induced embeddingWenjuan Shi, Tonghao Shen, Chengkun Xing, et al.
Frontiers in Medicine|June 28, 2021
Hospitalization Costs of COVID-19 Cases and Their Associated Factors in Guangdong, China: A Cross-Sectional StudyMoran Dong, Zuyao Yang, Yingyao Chen, et al.
Vaccine|March 21, 2026
Relative efficacy, safety, and immunogenicity analysis of two doses versus one dose of recombinant coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomized, double blinded phase 3 trialAdora Rooyakkers, Lingyun Ye, Pedro E Cahn, et al.
NPJ Vaccines|November 1, 2024
Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trialChun K Chew, Ruijie Wang, Sunita Bavanandan, et al.
Pageof 23

Showing results (221-230 of 225) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 225 results.
Nature Communications|July 23, 2022
Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatmentMoataz Reda, Worapol Ngamcherdtrakul, Molly A Nelson, et al.
Science (New York, N.Y.)|February 13, 2025
Ultrastable supported oxygen evolution electrocatalyst formed by ripening-induced embeddingWenjuan Shi, Tonghao Shen, Chengkun Xing, et al.
Frontiers in Medicine|June 28, 2021
Hospitalization Costs of COVID-19 Cases and Their Associated Factors in Guangdong, China: A Cross-Sectional StudyMoran Dong, Zuyao Yang, Yingyao Chen, et al.
Vaccine|March 21, 2026
Relative efficacy, safety, and immunogenicity analysis of two doses versus one dose of recombinant coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomized, double blinded phase 3 trialAdora Rooyakkers, Lingyun Ye, Pedro E Cahn, et al.
NPJ Vaccines|November 1, 2024
Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trialChun K Chew, Ruijie Wang, Sunita Bavanandan, et al.
Pageof 23